Early Contract Program about AACPi and ACPi | |
---|---|
Based on domestic and overseas market
research, robots or CSTDs that were developed for preparation are not
ultimately overcome Anticancer drug exposure (inevitable exposure in the
process of extracting from an anticancer drug container to B with a syringe,
needle, CSTD used for preparation, etc.) and selective dispensing, syringe,
needle, CSTD, and Medical wastes, etc.. But it was confirmed that AACPi and
ACPI were absolutely necessary because the work stress and workload of the
formulator was too much for the work that had to be done force majeure such as
problems. AACPi and ACPi have come to understand that there is no alternative
both domestic and overseas market. The preparation equipment AACPi and ACPi
includes barcode scanner and label printer functions and then, when the
dispenser orders from the control panel (PC) based on patient information,
prescription information, and dispensing information, it is automatically
dispensed and Barcode label including preparation information is printed by the
scanner and the prepared container and kit set are automatically packaged
without being separated, and the function of the automated equipment is to
attach a bar code to the packaging container. The scanner of H-100 Infusion
pump which is linked HIS can scan the bar code of the container prepared and
the bar code of patient information attached to the patient arm and these
functions will be minimized human error as much as possible. We intend to
complete product development and launch within the first quarter of 2021. First of all, with the existing Anyfusion
V100 model, as a prototype containing AACPi and ACPi functions, we are going to
conduct the demos with sequentially at 42 senior hospitals to help understand
the concept of AACPi and ACPi from September. We want to receive advice from hospital
officials, reflect them in product development, receive early orders with AACPi
and ACPi of the spec suitable for the hospital, and proceed with supply
contracts in order of order. If possible, the company's goal is to sign all of
the higher-level hospitals within this year. In addition, overseas market
research is also being conducted, and unlike Korea, which is hospitalized, but in
some countries, it was found that injections are performed at the oncology
clinic depending on the type of cancer patient. We have provided data to our
existing customers, such as the US, Japan, Germany, Saudi Arabia, Iran, and
Dominica, and are negotiating with the US, Saudi Arabia, and Iran. We are preparing to enter the overseas
market in earnest from the point of the end of COVID-19, and we intend to
complete all preparations for export from the second half of next year. Thank you. |
Next | Anyfusion Platform Business |
---|---|
Prev | Selected as Government support project for the usability test of FDA for Anyfusion |